Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma

Overview of attention for article published in Immunotherapy, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,620 followers.

Preparing this review article taught me so much about #allergicasthma and #CpGODN therapeutics and was a great catapult into my PhD thesis project! https://t.co/Np35xiwymT

RT @UIPharmaceutics: In press: Nanoparticle-Based CpG-ODN Therapy for Treating Allergic Asthma. Brittany E. Givens, Sean M. Geary and Alias…

In press: Nanoparticle-Based CpG-ODN Therapy for Treating Allergic Asthma. Brittany E. Givens, Sean M. Geary and Aliasger K. Salem. Immunotherapy. 2018. @UIPharmacy @UIowaResearch @StartWithGivens https://t.co/8bzyga8Ucn

Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma. https://t.co/sbJvBDhEtz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.